Anupam Rasayan India Acquires Control of Bliss GVS Pharma
Bliss GVS Pharma Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 12:10 am
Anupam Rasayan India Acquires Control of Bliss GVS Pharma Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited have acquired control of Bliss GVS Pharma Limited following the consummation of the Share Purchase Agreement dated 23rd May'26 and the completion of the open offer. Effective 28th Sep'26, both acquirers have been classified as Promoters of the company, alongside 13 affiliated entities added to the Promoter Group. Consequently, the company's Board took note of the reclassification of the erstwhile Promoters and Promoter Group to the "Public" category under SEBI regulations.
Original exchange filing (PDF)
More announcements from Bliss GVS Pharma Ltd
- Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations. 路 06 Nov 2026
- We wish to inform you that Asterisk Lifesciences Ltd, UK, a wholly owned subsidiary of Bliss GVS Pharma Limited, has obtained marketing authorization from the Medicines & Healthcare products .... 路 04 Nov 2026
- Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on October 29, 2026, the members has granted 2,95,000 stock options under Bliss .... 路 29 Oct 2026
- Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026 路 29 Oct 2026
- Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29, 2026 路 29 Oct 2026
- Please find attached the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. 路 29 Oct 2026
- Bliss GVS Pharma Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 29 Oct 2026
